Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial

Clinical Outcomes ◽

Basal Insulin ◽

Controlled Trial ◽

Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14354 ◽

2021 ◽

Cited By ~ 1

Author(s):

Rory J. McCrimmon ◽

Saud Al Sifri ◽

Rifat Emral ◽

Viswanathan Mohan ◽

Leobardo Sauque‐Reyna ◽

...

Keyword(s):

Type 2 Diabetes ◽

Basal Insulin ◽

Controlled Trial ◽

Randomized Controlled ◽

Baseline Characteristics

Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab‐2 randomized controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13806 ◽

2019 ◽

Vol 21 (10) ◽

pp. 2327-2332 ◽

Cited By ~ 2

Author(s):

Sylvia Franc ◽

Michael Joubert ◽

Ahmed Daoudi ◽

Cédric Fagour ◽

Pierre‐Yves Benhamou ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Basal Insulin ◽

Controlled Trial ◽

Insulin Initiation ◽

Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial

Diabetes & Metabolic Syndrome Clinical Research & Reviews ◽

10.1016/j.dsx.2014.09.001 ◽

2015 ◽

Vol 9 (4) ◽

pp. 271-276 ◽

Cited By ~ 37

Author(s):

Ruba A. Wishah ◽

Omar A. Al-Khawaldeh ◽

Abla M. Albsoul

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Pharmaceutical Care ◽

Clinical Outcomes ◽

Controlled Trial ◽

Randomized Controlled ◽

Health Related

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)

Diabetes Care ◽

10.2337/dc14-0990 ◽

2014 ◽

Vol 37 (12) ◽

pp. 3235-3243 ◽

Cited By ~ 169

Author(s):

Hannele Yki-Järvinen ◽

Richard Bergenstal ◽

Monika Ziemen ◽

Marek Wardecki ◽

Isabel Muehlen-Bartmer ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Glucose Control ◽

Basal Insulin ◽

Controlled Trial ◽

Randomized Controlled ◽

Oral Agents

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

Diabetes Care ◽

10.2337/dc19-1745 ◽

2020 ◽

Vol 43 (5) ◽

pp. 1085-1093 ◽

Cited By ~ 7

Author(s):

W. Timothy Garvey ◽

Andreas L. Birkenfeld ◽

Dror Dicker ◽

Geltrude Mingrone ◽

Sue D. Pedersen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Basal Insulin ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Overweight Or Obesity

Structured tool to improve clinical outcomes of type 2 diabetes mellitus patients: A randomized controlled trial

Journal of Diabetes ◽

10.1111/1753-0407.12799 ◽

2018 ◽

Vol 10 (12) ◽

pp. 965-976 ◽

Cited By ~ 4

Author(s):

Shamala Ayadurai ◽

V. Bruce Sunderland ◽

Lisa B.G. Tee ◽

Siti N. Md Said ◽

H. Laetitia Hattingh

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Clinical Outcomes ◽

Controlled Trial ◽

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2)

Diabetes Obesity and Metabolism ◽

10.1111/dom.12618 ◽

2016 ◽

Vol 18 (4) ◽

pp. 366-374 ◽

Cited By ~ 67

Author(s):

Y. Terauchi ◽

M. Koyama ◽

X. Cheng ◽

Y. Takahashi ◽

M. C. Riddle ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Glucose Control ◽

Basal Insulin ◽

Controlled Trial ◽

Japanese People ◽

Randomized Controlled ◽

Antihyperglycaemic Drugs

730-P: Basal Insulin Regimen vs. Twice-Daily Premix Insulin Regimen after Short-Term Intensive Insulin Therapy (SIT) in Patients with Type 2 Diabetes (T2D): A Multicenter, Open-Label Randomized Controlled Trial

Diabetes ◽

10.2337/db21-730-p ◽

2021 ◽

Vol 70 (Supplement 1) ◽

pp. 730-P

Author(s):

YIMING MU ◽

LIXIN GUO ◽

HAILONG WAN ◽

JUNFEN WANG ◽

BINHUA XU ◽

...

Keyword(s):

Type 2 Diabetes ◽

Intensive Insulin Therapy ◽

Basal Insulin ◽

Controlled Trial ◽

Insulin Regimen ◽

Short Term ◽

Open Label ◽

Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial

Journal of Diabetes Investigation ◽

10.1111/jdi.12654 ◽

2017 ◽

Vol 9 (1) ◽

pp. 119-126 ◽

Cited By ~ 6

Author(s):

Aika Miya ◽

Akinobu Nakamura ◽

Hideaki Miyoshi ◽

Kyu Yong Cho ◽

So Nagai ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Basal Insulin ◽

Controlled Trial ◽

Insulin Injection ◽

Injection Therapy ◽

Randomized Controlled ◽

Daily Insulin Injection

Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2018-00070 ◽

2018 ◽

Vol 103 (6) ◽

pp. 2291-2301 ◽

Cited By ~ 65

Author(s):

Helena W Rodbard ◽

Ildiko Lingvay ◽

John Reed ◽

Raymond de la Rosa ◽

Ludger Rose ◽

...

Keyword(s):

Type 2 Diabetes ◽

Basal Insulin ◽

Controlled Trial ◽